Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,020 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Amount and selectivity of proteinuria may predict the treatment response in post-transplant recurrence of focal segmental glomerulosclerosis: a single-center retrospective study.
Ban H, Miura K, Kaneko N, Shirai Y, Yabuuchi T, Ishizuka K, Chikamoto H, Akioka Y, Shimizu S, Ishida H, Tanabe K, Hattori M. Ban H, et al. Among authors: tanabe k. Pediatr Nephrol. 2021 Aug;36(8):2433-2442. doi: 10.1007/s00467-021-04951-x. Epub 2021 Feb 4. Pediatr Nephrol. 2021. PMID: 33538912
Oral vs intravenous tacrolimus-based induction therapy in renal transplantation.
Tojimbara T, Kimikawa M, Nakajima I, Sato S, Nakamura M, Ishida H, Tanabe K, Koyama I, Utsumi K, Sannomiya A, Tsuji K, Fuchinoue S, Agishi T. Tojimbara T, et al. Among authors: tanabe k. Transplant Proc. 1999 Nov;31(7):2763-4. doi: 10.1016/s0041-1345(99)00558-8. Transplant Proc. 1999. PMID: 10578282 Clinical Trial. No abstract available.
Clinical utility of monitoring sialyl Lewis(X) (CD15S) antigen on peripheral lymphocytes for the diagnosis and treatment of rejection after renal transplantation.
Ishida H, Koyama I, Sawada T, Murakami T, Utsumi K, Sannomiya A, Tsuji K, Tojimbara T, Nakajima I, Tanabe K, Fuchinoue S, Yamaguchi Y, Toma H, Agishi T. Ishida H, et al. Among authors: tanabe k. Transplantation. 2000 Jan 15;69(1):59-63. doi: 10.1097/00007890-200001150-00012. Transplantation. 2000. PMID: 10653381
ABO-incompatible pediatric kidney transplantation in a single-center trial.
Ohta T, Kawaguchi H, Hattori M, Takahashi K, Nagafuchi H, Akioka Y, Mizushima W, Ishikawa N, Tanabe K, Toma H, Takahashi K, Ota K, Ito K. Ohta T, et al. Among authors: tanabe k. Pediatr Nephrol. 2000 Jan;14(1):1-5. doi: 10.1007/s004670050001. Pediatr Nephrol. 2000. PMID: 10654320 Clinical Trial.
Sialyl Lewis(x) (CD15s) monitoring as a means to select antirejection therapy in patients with rejection after renal transplantation: CD15s monitoring for treatment and diagnosis in patients with acute rejection after renal transplantation.
Ishida H, Koyama I, Sawada T, Murakami T, Tojimbara T, Nakajima I, Tanabe K, Yamaguchi Y, Fuchinoue S, Toma H, Agishi T. Ishida H, et al. Among authors: tanabe k. Transplantation. 2000 May 27;69(10):2208-11. doi: 10.1097/00007890-200005270-00046. Transplantation. 2000. PMID: 10852628
3,020 results